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SUMMARY
Three personal hygiene cleansing agents (Neutrogena bar soap,
Miranol JEM concentrate: and Olive Leaf) and one laundry detergent (sodium
dodecyl benzene sulfonate), which are candidates for use on long-duration
space missions, have been evaluated in terms of dermatological effects on
human subjects and effects on microbiological species. None of the four
materials exhibited adverse dermatological effects from skin patch tests
of two weeks duration, and Neutrogena and Miranol JEM exhibited no adverse
dermatological effects in a simulated Skylab personal hygiene regimen of
up to four weeks duration (the other two products were not tested in this
manner). Neutrogena and Miranol JEM also produced no significant altera-
tions in skin microflora during the use regimen.
None of the four materials were found to serve as microbiological
support media for the species tested, but a species of air-borne mold was
observed to grow rapidly in a neutralized aqueous solution of Neutrogena.
None of the candidate agents was found to be strongly biocidal.
Of the four agents, only Neutrogena was found to exhibit gellation
and/or precipitation in aqueous solutions over the pH range of ?..5 to II.0.
This solution instability could pose problems if local pH excursions are
allowed to occur in a washwater reclamation system in which Neu-rogena is
removed.
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l.O INTRODUCTION AND BACKGROUND
The overall objective of this program was to identify and evaluate
any potential hazards to crew and to a washwater reclamatioF_ system which
might result from the use of Miranol JEM and Neutrogena, the personal
hygiene cleansing agents currently proposed by NASA for Skylab and SSP.
Types of potential hazards which were to be considered included:
(I) Adverse dermatological effects --Allergic and sensitization
reactions, drying, and other irritant reactions, etc.;
(2) Adverse effects on skin microflora --neither complete
removal nor growth enhancement of the skin microflora would
be desirable;
(3) Enhanced growth of potentially pathogenic species -- on
the skin, on the surface of the Neutrogena, in the personal
hygiene area, or in the washwater;
(4) Incompatibility of the personal hygiene agents with reverse
osmosis membranes --causing hydrolysis, excess swelling,
or decreases in throughput due to suspended solids, colloids,
or gels; and
(5) Other potential hazards associated with a washwater recovery
system--salting-out of solids, line plugging, chemical
instability leading to gas formation, etc.
The program was to be conducted in three phases, wiLh Phase I the
dermatological and microfloral studies, Phase II the identification and
evaluation of potential hazards, and Phase III the testing of compatibility
of Miranol JEM and Neutrogena with reverse osmosis membranes. Dr. Jack M.
Spurlock was the Principal Investigator for the program, with Dr. Frank C.
Whitmore in charge of the effort on Phases I and II and Dr. Robert L. Durfe
in charge of the Phase III effort. The microbiological preparations and
analyses for Phase I were performed under the direction of [_. William F.
Enos and Mr. William Sellers, at the Pathology Laboratory, N)rthern Virgir:i_
Doctors Hospital, Arlington, Virginia.
At the request of the Contracting Officer, Phase III of the
program was deleted and a preliminary screening of Olive Leaf and Sodium
Dodecyl-Benzene Sulfonate for acute dermatological effects and for the
ability of these cleansing agents to support growth of potentially patho-
genic species of microflora was substituted. A detailed evaluation of
the potential system hazards from any of the four cleansing agents and
from mixtures of these materials is not complete, in the sense that
items (4) and (5) above remain to be evaluated.
Ixc.
2.0 EXPERIMENTAL RESULTS FROM SOAP EVALUATION STUDIES (Pha_e I)
2.1 Characterization of Personal Hygiene Soap Products
Although a number of cleansing agents are being useH by the varioJ_
NASA centers and contracts in programs concerned with the personal hygiene
regimen, washwater characterization, hardware design and dew_lopment, and
washwater reclamation, we have concluded that Miranol JEM cor_centrate and
unscented Neutrogena are the two personal hygiene products mest likely to
be used on Skylab.
The Skylab regimen calls for use of 8 gm of the Mir_nol JEM con-
centrate in a weekly shower with about 6 Ibs. of water. The Miranols are
amphoteric surface active agents having cationic and anionic groups of
equal strength (isoelectric point at pH 7.0) and a pH of sli_ijhtly above 9._]
when made up as aqueous solution.
Neutrogena is a proprietary formulation of a "super-fatted" soap.
It is widely used by persons with dermatological and allergic problems.
It produces the alkaline aqueous solution typical of soaps, but its struc-
ture and physical-chemical properties are not generally knower. It is a
mixture of several components. However, the manufacturers of Neutrogena,
like the Miranol Co., have been very cooperative in furnishing samples and
available technical information. The aqueous solutions of N_utrogena have
a normal pH of about 9.3.
2.2 Test Methods and Protocol for Dermatological and Skin
Microfloral Testing
2.2.1 Selection of Use Regimen and Schedule
The bathing regimen (using Neutrogena and Miranol JEM concentrate
finally selected represents something of a compromise betwee_ the several
possible Skylab protocols and the practical necessities inherent in this tjF
of an experiment. The instruction sheet issued to each subject at the
outset of the test program is included on Table I. This sheet summarized
the final form of the regimen.
2.2.2 Selection of Subjects
It was determined that twenty subjects divided into two groups,
Group A with twelve members and Group B with eight members, represent a
sample that is large enough for statistical purposes, and yet small enough
to generate a manageable number of bacteriological samples. The actual
subjects represent a rather wide selection of skin types, including several
blacks, and are of both sexes. Each subject signed a permission sheet and
had the program and its purpose carefully and fully explained.
Group A (twelve) were medical technicians and students from a
local college who were involved in the skin flora/bath regim_n for approxi-
mately six weeks. Group B were mostly older persons with widely diverse
environmental backgrounds who were involved in the skin flora/bath regimen
for approximately four weeks. Each group of subjects was studied for
normal skin flora for approximately one week while maintaining their norma|
personal hygiene regimen. After a base line was established for each sub-
ject, Group A followed the simulated Skylab personal hygiene regimen for
a total of four weeks during which skin flora measurements were taken for
the first two weeks. The extent of the test was such that ar_y evidence of
adverse dermatological response to chronic use should have s_own up. At
the conclusion of the four week simulation, the subjects of Group A returnee
to their normal hygiene regimen. Data on the return to "non_al" microflor_
were taken during this last week. Group B followed essentially an identical
regimen except for the shorter period on the Skylab regimen (one week).
This group was also tested for acute dermatological effects.
2.2.3 Sampling and Test Procedures
A total of six body sites were selected for sampling:
TABLE I
INSTRUCTIONS FOR PARTICIPANTS IN THE SKYLAB PERSONAL HYGIENE PROGR_,I
In order to determine the efficiency of the soap compounds to be u_,e
in the 28-day and the 56-day flights of Skylab scheduled to occur within the
next few years, Versar has contracted to NASA to carry out this preliminary
study. You, as a volunteer participant, will be asked to follow the regime_
for personal hygiene that is outlined below. We hope that in the interests o
carrying out a definitive study, you will follow the procedure as closely as
is possible:
Sunday morning:
Shower using 6 pounds (about 1 gal.) of I05°F water and 8 grams Mira
JEM. The subject should wet down, rub on the Miranol and work into the skin
several moments. (Hair should be washed at this time). Use the remainder of
allotted water to rinse off. Towel dry with a clean terry cloth towel.
Tuesday and Friday morning:
Sponge bath using moistened wash cloth coated with Neutrogena for
full body bath. Rinse with moistened cloth until soap is removed.
Monday, Wednesday, Thursday and Saturday morning:
Wipe off using almost dry cloth with Neutrogena for whole body wipE-
down. Wipe off with nearly dry cloth.
Hands & Face:
Hands and face may be washed with dampened cloth and i_eutrogena at
any time but not more often than five (5) times per day.
At the end of the first week of this regimen, each subject will be
asked to report for skin swabs at 1300 hours for each day of the next seven
days. The sampling sites and procedures will be identical to those for the
baseline data.
Group A will continue the hygiene regimen for a total of 28 days ar;d
will be examined biweekly for s gns of dermatological effects. Group B will
continue the specified regimen for two weeks or until a satisfactory picture
of their skin flora is obtained.
a. Left ear canal
b. Right axillary
c. Back of left hand
d. Upper right thigh at crotch
e. Upper left thigh at rectum
f. Bottom of right foot
Sampling was accomplished by wiping an area of approximately 3 square cm.
with a cotton swab moistened with buffered sterile saline solution.
Tubes and swabswere madeavailable for the subject to makehis (or her)
own sampling at approximately 1300 hours on the test days.
On return to the laboratory the 0.5 ml water and swab was diluted
to 1.0 ml with sterile saline and plated on Blood Agar, EMB,Maqnitol
Salt, Thioglycolate broth and Sabourand. These cultures are incubated at
37°C and read at 24 and 48 hours. Data were obtained in terms of general
types of organisms and approximate numbersof each.
2.3 Results of Simulated Skylab Regimen --Microfloral
Effects
The data obtained from this portion of the program are too volumi-
nous to be included in the text; therefore, they are included a; Table VII
in Appendix I to this report. Table VII contains both baseline data and
data obtained during the simulated Skylab regimen for each subjmt tested.
A discussion of the results is presented below.
In order to present the experimental data of Appendix I in a form
which most easily lends itself to interpretation, the individual sets of
triplicate plates for each medium and each site have been averaged. In addi-
tion, although a more detailed identification was made in many cases, the
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numerical results are presented as average numbers of gram neg_tive cocci,
gram negative rods, yeasts and molds. In only one case was a gram positive
cocci observed. Although this method of presentation serves to suppress
much of the detail of the experiment, it does adequately and correctly express
the general results. A few cases wherein significant changes in the complex-
1"on of the microfloral population appear to have occurred are presented in
detail in Table VIII of Appendix I. In addition, several plots of the total
population vs. time are presented on Figures I-5 of Appendix I. These plots
show the surprisingly large daily variations in microfloral population in
addl'tion to the lack of significant variations associated with the experi-
mental bath regimen.
The gram negative cocci were overwhelmingly staphyloc,)cci and
a streptococci. The gram negative rods were predominantly proteus, E. Coli,
diptheria and enterobacter. The rarely found yeasts were not identified
specifically. In a number of cases wherein no growth (-) is reported in
Appendix I, colonies were found in the thioglycolate broth even though there
was no growth in the solid media.
The computation of the average number of organisms per unit area
of the sample site cannot be very precisely computed from the data in
Table VII of Appendix I, since there was apparently considerable variation
in the degree to which the subject expressed the saline solutioF_ from the
swab prior to taking the swab sample. This variation could be expected to
alter the dilution factor which, coupled with the statistical v_riations in
taking the samples for culturing, introduces considerable unceri:ainty in
reducing the actual numbers to estimates of total surface popul._tion.
In order to give some estimate of the variations intr_duced by
the experimental procedure, a known concentration of lactobacteria suspended
in sterile buffered saline was spread over a I0 cm2 area on a clean glass
plate. Swabs prepared as in the skin microflora experiment were] used to
wipe an area of 3 cm2. Subsequent treatment exactly as used in the skin
microflora experiment suggest variations in count by an average factor of
three to four _ for the computedsurface concentration. On the other hand,
the sampling error anticipated from taking three successive 0.001 ml samples
from a suspension in 1.0 ml of sterile buffered water is (for the low con-
centrations of organisms expected) probably of the sameorder of magnitude in
the opposite direction (a factor of three or four too low).
In spite of the uncertainties in numbers, repeated experiments with
specific subjects indicate a rather constant error in sampling indicating
that the relationship between successive samples taken by a particular sub-
ject are consistent and therefore comparable.
The experimental results obtained indicate (as shown in the Appendix
particularly Table IX) that there is no significant variation in the distri-
bution or total population of skin microflora associated with the simulated
Skylab personal hygiene regimen.
2.4 Results of Dermatological Testing
2.4.1 Dermatological Effects of Miranol and Neutrogena
The two cleansing agents selected by NASA for use on Skylab,
Miranol JEM Concentrate and Neutrogena, have been tested for dermatological
effects. Miranol is a liquid amphoteric surfactant (Miranol Chemical Co.,
Livingston, N.J.) used as an ingredient in baby shampoos and other related
products, while Neutrogena is a bar soap (Neutrogena Co., Santa Monica,
Calif.) advertised as "hypoallergenic" and suitable for persons with some
dermatological problems ("sensitive skin"). Con_nercial Neutrogena is
available in scented and unscented forms. Thus, both candidate_ appear
to be excellent choices in terms of minimal direct dermatologic_l effects
--- a point which was verified by test results from some twenty :_ubjects
for either acute or chronic exposure effects. These tests indicated no
adverse effects for any subject.
Twelve subjects were tested for reaction to the two s_aps following
routine exposure of the hands, arms, and axillae. Each subject received
a detailed skin examination prior to testing to identify any condition
which would bias the result. Weekly examinations were made to identify any
apparent reaction. Use was as prescribed by NASA for Skylab arJJ SSP.
Since no reaction occurred for any subject, testing on that subject was
continued for 28 days after which a complete examination of the skin was
performed. No adverse reaction of any kind was observed during these
examinations. As an aside, one male subject who has had a chronic local-
ized foot infection reported that the Neutrogena/Miranol regimen offered
him some relief from this condition, but this observation did not corres-
pond to any observable change in his typical microflora at the :Jesignated
sampling areas.
A second series of tests were performed on the other eight sub-
Jects. These tests consisted of skin patches on the arms and back of
each subject, using a 2 per cent aqueous solution of the test soap. These
tests were started on the first day of a week and subjects were examined
for reactions on the third and fifth day. In the absence of a reaction,
the patches were removed for the weekend, and fresh patches were applied
on the first day of the following week. The cycle was repeated for a
second week.
This second group showed no adverse reaction to the a,-ute
exposure. The absence of reaction was determined in each case by the
subjective reaction of the subject coupled by examination by a competent
authority. Incidentally, the twenty subjects included six (6) Females
and four (4) blacks and represented a wide variation in skin types.
2.4.2 Acute Dermatological Effects of Sodium Dodecyl-Benzene
Sulfonate (NDBS) and Olive Leaf (OL)
A mixed group of subjects was tested for dermatologic]l reaction
to the test soaps by a regimen essentially identical to that de:scribed in
the preceding subsection (Section 2.4.1). Each subject had a I" x I"
sterile gauze patch, moistened in the center with 0.25 ml of a 2 per cent
(2 grams agent in I00 ml water) solutiOn of the cleansing agent affixed to
his upper left arm. The patches were affixed on Mondayand allowed to
remain until Friday for a total exposure of five days. The identical
test was repeated for a second five day period. Upon removal the affected
area was examined for reaction and rated on a numerical scale _-anging from
0 - no observable reaction to 5 - extreme dermatitis.
The results of these tests for NDBSand OL have showr_a consis-
tent 0 rating for all tested subjects (19 in all).
2.5 Effects of Miranol JEM and Neutrogena on Growth of
Microbiological Species
2.5.1 Test Matrix for Effects of Soaps on Microbiological
Species
In order to determine, in at least a gross manner, the direct
pgysiological effects of Miranol and/or Neutrogena on skin mic_oflora
and other microbiological species a test matrix was established using:
(I) Blood agar plus 5% sheep cells, (2) EMB and (3) Mannitol salt plates
as standard growth support media. The soaps were used as aqueous solu-
tions made up in concentrations of I%, 3%, 5%, and 10% by weight. The
experimental protocol was established according to the guideli_es set up
as a test matrix shown in Table II.
The test media used were Blood Agar with 5% Sheep Erythrocytes,
mannitol salt and eosin methylene blue agar. In the case of Test Series
A, an attempt was made to identify, at least by species, the organisms
which developed following a twelve (12) hour exposure to ambie_t labora-
tory air.
72.5.2 Results of Series A
Six BAP plates and six EMB/MS biplates were covered with
1.0 ml of the appropriate soap solution in each of the made-up concentra-
tions and subsequently exposed to the laboratory airborne organisms for
twelve hours. After exposure, the contaminated plates were incubated at
37°C. Plates of the same media covered with 1.0 ml sterile water served
as controls. The incubated plates were read at 24 hours and at 48 hours
for number and type of colonies present. A new set of test and control
plates were exposed on each of three successive days.
A set of typical data from this exposure are shown below (only
the 48-hour incubation is shown) as developed colonies:
Control BAP
Control EMB/MS Biplate
Neu rogena I% BAP
" 3% "
° " 5% "
" 10% "
" I% MS/EMB Biplate
" 3% "
" 5% "
" 10% "
Miranol I% BAP
" 3% "
" 5% "
" 10%
" 1% MSIEMB Biplate
" 3% "
" 5% "
" I0% "
12 $taph; 6 Dipth; 1 Yeast;
1 Mold
3 Staph; 1 Mold
I0 Staph; 9 Dipth; 3 Yeast
19 Staph; 14 Dipr.h
8 Staph; 12 Dipti_
2 Staph ;
3 Staph; 1 Yeast
No growth
No growth
1 Mold
!0 Staph; 1 Yeas_
9 Staph; 5 Dipth; 2 Mold
13 Staph; 2 Mold
1 Staph; 2 Dipth
1 Staph; 2 Coag(-) Staph; 2 Mcl
2 Coag(-) Staph
1 Mol d
No g rowLh
= Ixc.
TABLE II
Test Matrix for Cleansing Agent Effects on Microbiological Growth Rates
Test Series A - Open Exposure of Culture Medium to Airborne Organisms
(Clinical Environment)
Control - Sterile culture media; no cleansing agent.
Test Conditions - Sterile culture media plus addition of cleansing
agent solutions (in distilled water) at concer_trations
up to ten per cent by weight; ambient-temperature
culturing.
Test Results - Colony counts by gross species.
Test Series B - Exposure of Culture Medium to Washw_er Samples from
Selected Human Subjects
Control
- Sterile culture media plus addition of washw_ter
samples (washwater consists of distilled watcr only).
Test Conditions - Sterile culture media plus addition of cleansing
agent-washwater samples (washwater consists of two per
cent by weight cleansing agent); ambient-temperature
culturing.
Test Results - Colony counts by gross species,
Test Series C - Inoculation of Support Medium with Selected Organisms to
Determine the Ability of the Soaps to Serve as Growth Medid
Control
- Sterile support media inoculated with desire_! species;
no cleansing agent (standard incubation conditions).
Test Conditions - Sterile support media plus cleansing a_ent solu-
tions (up to ten per cent) inoculated with:
(a) Predominant and growth-accelerated speci_s
from Test Series A;
(b) Predominant and growth-accelerated speci_s
from Test Series B;
(c) Other species selected for potential sig_ificance.
Standard incubation conditions.
Test Results - Colony counts by gross species.
The results of this experiment indicate no significant differ-
ence between the controls and the treated plates. The conclusions resulting
from this test suggest that neither Miranol nor Neutrogena exhibit biocidal
effects. There is some slight indication of a longer range retL_rdation of
growth observed with the more concentrated Miranol solutions (51 or higher)
suggesting a slight biostatic effect.
2.5.3 Results of Series B
In order to refine the results of Test Series A, six hAP plates
and six EMB/MS biplates were inoculated (by streaking) with pure cultures
of representative organisms and subsequently covered with 1.0 r_l of the
test soap solutions (using the same soap concentration range as simulated
washwater as in Test Series A). The test organisms and their standard
concentration, as determined by serial dilution, were as followL:
E. coli
pseudomonas
streptococci
coagul ase positive
staphylococci
coagulase negative
staphylococci
yeast
~ 10S/mi
~ lOS/ml
~ 2.6 x 104/ml
~ 2.6 x 104/ml
~ 1.5 x lO"/ml
lOS/ml
After inoculation (standard loop 0.001 ml) and the introduction of the test
washwater solution, the plates were incubated at 37°C for 48 hours before
reading. The controls were treated as in Test Series A. In all cases,
there were no statistically significant differences between the controls ant
the test plates.
2.5.4 Results of Series C
In order to determine the extent to which Miranol JEM and Neutroge_
in aqueous solution can serve as biological support media, l.O ml of the
same standard inoculation as in Test Series B was introduced with 5.0 ml
of the standard soap solutions at each concentration. A similar inocula-
tion with 5.0 ml of sterile buffered water served as control. The inoculaCE
tubes were incubated at 37°C for 48 hours and read by the removal of O.OOl
ml of the suspension which was streaked on the basic (EMB) support media.
A typical set of results for the streaked plates is shown in Table III,
which shows that neither soap is capable of serving as a microfloral sup-
port medium.
There is underlying these conclusions a possible loophole that
should be more deeply explored. The aqueous solutions of both Miranol JEM
and Neutrogena have pH values above 9. In the presence of typical nutrient
culture media (as in Test Series A and B), the buffering cap_:bilities of
the media are sufficient to maintain the whole system (aqueous soap solu-
tion/culture medium) at a pH near 7.0. On the other hand, tke incubation
of the organisms in the soap solution for 24 or 48 hours pricer to their
inoculation onto culture media as was the case in Test Serie! C raises
the question of the relative effect of the soap as compared i:othat of the
high pH value. In order to test this, 2 per cent solutions of Neutrogena
and of Miranol JEM in water were neutralized by the addition of 0.3 N HCI
to a final pH of 7.0. Tubes were inoculated with test cultures, incubate J
for 24 and 48 hours at 37°C, then plated on EMB plates --following exactly
the procedure of Test Series C. The results of such an experiment are
TABLE III. Results from Exposure of Various Microorganisms to
Soap Solutions - Culture on EMB Plates
Soap Solution
Species
E. coli
Pseudo
m-strep
0 staph
0 staph
Yeast
Species
E. coli
Pseudo
m-strep
staph
0 staph
Yeast
Species
E. coli
Pseudo
m-strep
0 staph
0 staph
Yeast
24 hr. Readin 9
I% 3% 5% 10%
Neutroqena
NG NG NG NG
l NG NG NG
NG NG NG NG
NG I00 I00 _50
m50 m50 NG NG
m50 2 NG NG
Miranol JEM
1 NG NG NG
NG NG NG NG
NG NG NG NG
NG NG NG NG
NG NG NG NG
NG NG NG NG
Control
over I00,000
over I00,000
over lO0,O00
26,000
15,000
over lO0,O00
48 hr. Reading
i I% 3% 5% I0
Neut_-oqena
NG NG NG N_
l NG NG N[
NG NG NG N(
NG t10@ t100 ]1( ,
IlO0 flO0 m50 ,_ -
t I00 2 NG NE
Miranol JEM
1 NG NG HG
NG NG NG fig
NG NG NG riG
NG NG NG []G
1 5 9 I_G
NG NG NG I_G
Control
over lO),O00/cc
over lO0,O00/cc
over lO'),O00/cc
26,000/cc
22,000/,:c
over lOii,O00
shown in Table IV for Neutrogena.
The results shown on Table IV did raise the question of possible
support by Neutrogena for the growth of pathogenic organisms at pH levels
near neutral. Repetition of the neutral solution tests of Table IV utili-
zing serial dilution techniques yielded quantitative results showing that
the organisms per unit volume in the Neutrogena solutions were the same
as those (controls) in which no Neutrogena was present. Thus, it appears
that Neutrogena at neutral pH was only an inert ingredient causing no
effect on microbiological growth.
In direct contrast, Miranol JEM solutions at pH 7.2 showed
exactly the same results as at pH 9 (shown in Table III) -- the biostatic
effect is clearly a function of the cleansing agent and not/of the solu-
ti on pH.
2.6 Effects of Sodium Dodecyl Benzene Sulfonate and Olive
Leaf on Microbiolog"ical Species
In order to determine, in at least a gross manner, the direct
physiological effect of Sodium Dodecyl Benzene Sulfonate NDBS) and Olive
Leaf on representative skin microflora, a test matrix was established
using Blood Agar with 5% sheep cells, EMB and Mannitol salt i lates as
standard growth media. The soaps were prepared as aqueous selutions in
concentrations of up to 10% by weight in distilled water. Tke format
of the test matrix was shown in Table II.
2.6.1 Results of Series A
Six BAP plates and six EMB/MS biplates were covered with
1.0 ml of the appropriate soap solution in each of the made-up concentra-
tions and subsequently exposed to the laboratory air-borne organisms for
twelve hours. After exposure, the contaminated plates were incubated at
37°C. The incubated plates were read at twenty four and forly eight hours
TABLE IV.
The Effect of pH on the Ability of a Soap Solution tc_ Support
Bacterial Growth
Organism
2% Neutrogena in Water at pH 9.3
24 48 24 48 24 48 24 48 24 4_
A
B
C
D
E
F
G
12 15 25 32 -
- 1 - - 1 2
13 50 - I0 24 57
3 4 - - II 12
m
n
N
m
Organism 24 48
2% Neutrogena in Water at pH 7.2
24 48 24 48 24 48 24 4_
A >I O0 >I O0 >I O0 >I O0 >I O0 >I O0 >I O0 >I (10 >I O0 >I ,J(
B >I O0 >I O0 >I O0 >I O0 >I O0 >I O0 >I O0 >I (;0 >I O0 >I OC
C >I00 >I00 >I00 >I00 >I00 >I00 >I00 >I_)0 >I00 >I0_,
D >I00 >I00 >I00 >I00 >I00 >I00 >I00 >I()0 >I00 >I0(_
E >I00 >I00 >I00 >I00 >I00 >I00 >I00 >IC!O >I00 >I,.3(
F >I00 >I00 >I00 >I00 >I00 >I00 >I00 >I (__0 >I00 >IOC
G >I00 >I00 >I00 >I00 >I00 >I00 >I00 >I00 >I00 >IOC
Key: A - E coli
B - m Strep
C - _ Strep
D - _ staph
E - 0 staph
F - Pseudomonas
G - Proteus
for number and type of colonies present. A new set of test and control
plates (control plates were covered with 1.0 ml sterile water) were
exposed on each of three successive days.
The results of this experiment indicate no significcmt differ-
ence between the controls and the treated plates. These results lead to
the conclusion that both components were essentially inert components of
the medium during this test series.
2.6.2 Results of Test Series B
Six BAP plates and six EMB/MS biplates were covered with
1.0 ml of cleansing agent-wash water samples and incubated at 37°C. The
wash water sample was prepared by having several subjects repeatedly
wash their hands in a 2% (by weight) solution of the appropriate cleans-
ing agent. The control plates were covered with 1.0 ml of distilled
water. The contaminated plates were read after 24 and 48 hours of incuba-
tion.
The results of this experiment again showed no significant dif-
ferences between wash water samples and controls.
2.6.3 Results of Test Series C
In order to determine the extent to which the test cleansing
agents, NDBS and OL, in aqueous solutions can serve as biological support
media, a series of test organisms were introduced into variots concentra-
tions of the cleansing agent, held at incubation temperature for 24
hours, then streaked on Blood Agar plates.
The test organisms used were as follows:
A - E coli
B - a Strep
C - _ Strep
D - + st:,ph
E - - staph
F - pseudomonas
G - Proteus
A suspension of each of the test organisms was prepared by i_oculating
1.0 ml of sterile water with 0.002 ml of the culture. Sterile tubes con-
taining 1.0 ml of each of the cleansing agents at each conce_tration were
then inoculated with 0.001 ml of the test suspension. Controls consisted
of sterile tubes with only the cleansing agent solutions without the
inoculation and a set containing 1.0 ml of the bacterial suspension. The
tubes, contaminated and controls, were then incubated at 37°C for 24
hours.
After incubation, blood agar plates were streaked with 0.001
ml of each test solution. The contaminated plates were incubated at 37 °
and read after 24 and 48 hours. The same procedure was followed after a
48-hour incubation of the original sample tubes.
The results of these experiments are tabulated in Table V wherein
the data have been averaged over each duplication.
The results of this experiment indicate that both cleansing agents
exhibit biocidal activity toward gram-positive organisms at all concentra-
tions of the cleansing agents and the sodium dodecyl benzene sulfonate had
no effect on the concentration of the gram-negative organism_. On the
other hand, the Olive Leaf solution at concentrations at 3 p_r cent or
above seems to be uniformly an inhospitable medium for all oC the tested
organisms.
The data presented in Table V could be somewhat misleading in
that there is a considerable difference in the pH of aqueous solutions of
01ive Leaf as compared to those of the sodium dodecyl benzen_ sulfonate.
The latter solutions have an adjusted pH of about 7.0 to 7.2 whereas the
Olive Leaf solutions typically exhibit pH values above 9.0 a_d perhaps as
high as 9.3. Since the test organisms generally prefer pH v,_lues near 7.0,
there may be concern that the high pH values of the soap sol_tion, coupled
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with the lack of buffering associated with sterile water systems, could
account for the apparently biocidal effects of Olive Leaf solutions as
compared to the NDBS. To test for such a pH effect, a 2 per cent by
weight solution of Olive Leaf in distilled water was neutral zed by the
addition of O.IN HCl to a final pH of 7.0. The results of Test Series C
on such a solution are shown in Table VIo
A comparison of the 1 and 3 per cent solution data in Table V
with the data in Table VI suggests that, in strong contrast i:o the results
with Neutrogena, there appears to be little pH effect on the biocidal
activity of Olive Leaf.
2.7 Other Tests of Microbiological Support with Candid_t_ee
Cleansing Agents
2.7.1 Possible Contamination of As-Received NeutrQgena
Thin slices were taken from five samples of as-received Neutrogena
bars to determine if any microbiological contamination was present. These
samples were imbedded in various media and incubated for 48 hours. No
evidence of any as-received contamination was found.
2.7.2 Exposure of Neutralized Aqueous Soap Soluti_n to
Laboratory Air
Several samples of each of the four cleansing agents (as 2 per
cent aqueous solutions neutralized to an approximate 7.0 pH) _vere exposed
to laboratory air for one month. At the end of this period one sample
of Neutrogena solution exhibited a fairly large spherical grc_wth (about 1 c_E
in diameter) which appeared to be some type of dark-colored r_eld. The
growth was floating on the surface of the liquid.
In order to further investigate the phenomenon described above,
five samples of 2 per cent Neutrogena in distilled water, with pH reduced
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to 7.8 by the addition of HCI solution, were exposed for five days to
ambient air at about 75 ° in our analytical chemistry laboratory. After this
exposure, the samples were sealed and allowed to stand at ambie_t temperatur_
for three weeks. At the end of three weeks one of the samples <ontained a
large roughly spherical growth of a mold on the bottom of the p astic bottle.
The growth was about 1.5 cm. in diameter and was black in color The rapid
growth rate of the mold and the size attained appear to indicate that the
Neutrogena was being utilized to support its growth, since few other poten-
tial nutrients were available.
The mold described above appeared similar in growth habit and
color to the specimen described previously. However, the new s_mple grew
at the bottom of the container and was more dense than the solution whereas
the previous sample was less dense than the solution and grew at the water-
air interface.
The mold required several weeks to grow to a signific_mt size in
various culture media (apparently, it grew more quickly in the soap solution
than in the various media used). Although preliminary indications were
that it was not an Aspergillus, further investigations indicated that,
to approximately 90 per cent confidence, the growth was some specific type
of Aspergillus, but was not an A. Niger.
We must conclude from this result that there are specific micro-
organisms which can utilize Neutrogena in aqueous solution as a growth medium.
The mold described above is the only species for which this has been demon-
strated.
3.0 EVALUATION OF POTENTIAL HAZARDS FROM THE USE OF MIRANOL JEM AND
NEUTROGENA (PHASE II)
Work on this phase was subdivided into the following subtask
headings:
(1) Interpretation of the results from Phase I and the
assignment of any potential health hazards to crew
members ;
(2) Investigation and evaluation of possible hazards to
reverse osmosis (RO) membranes with inputs from
Phase III; and
(3) Definition and evaluation of other possible hazards
to the washwater recovery system.
3.1 Potential Health Hazards to Crew Members
The results of Phase I indicate that there should be no adverse
dermatological effects following the use of either or both of these
personal hygiene agents. No significant changes in the normal skin micro-
flora were noted. In addition, in spite of the rather restricted use of
water and the infrequency of whole body showers, all of the test subjects
indicated a surprising feeling of being clean. Clearly, the potential
health hazards to crew members associated with the simulated Skylab
personal hygiene regimen appear to be minimal.
3.2 Hazards to RO Membranes
Due to the alteration of the Work Statement which s:bstituted a
preliminary evaluation of acute dermatological effects and l_:boratory
testing for microbiological compatibility of a laundry detergent and
another personal hygiene agent, the RO membrane compatibilit5 work was
discontinued.
3.3 Possible Hazards to Washwater System
Neutrogena is a complex mixture exhibiting significant buffering
capability over a rather wide pH range (9 to 5.5) with several breaks through-
out this range- suggesting the differing isoelectric points of the several
components. Below a pH of approximately 5.0, the solubility of at least
one component is sharply reduced, and a gel is produced which gradually coagu-
lates into a surface scum. At very low pH (3.0 or below) the precipitate
rapidly becomes flocculated and is easily filtered. Subsequent to filtratior_,
the resulting solution exhibits little or no buffering capability and no soap
action. If the initial solution of Neutrogena is adjusted to high pH (about
II.0), a semi-rigid gel is formed which can be dispensed by subsequent reduc-
tion of the pH. These observations would suggest that Neutrogena could cause
serious problems in an RO washwater recovery system especially under condition.
where the pH is adjusted to match the (low) pH range that is optimum for RO
membrane performance.
The behavior described above seems to be inherent to the formulation
of Neutrogena. Composition information from the basic Neutrogena patent
is presented below, but significant deviations from this formulation cannot
be ruled out.
Component
Sodium soap (saponified tallow,
coconut oil and castor oil)
Triethanol ammonium salt of Stearic Acid
Triethanolamine, glycerine, perfume
Percentage by Weight
35-40
35-40
unspecii_ied
In contrast to Neutrogena, Miranol JEM, Sodium Dodecyi benze:_.e
sulfonate and Olive Leaf show much simpler behavior under wide i_H ranges. All
_k
"Soaps and Their Method of Preparation", U.S. Patent No. 2,820,768, 21 Jan. I'
these materials exhibit considerable buffering action at or nea_ the normal
pH values of their aqueous solutions. Noneof these cleansing agents showed
any significant tendencies toward gel formation, at least in concentrations
of up to 2%by weight in water, over the pH range 2.5 to Iio
In summary, a tentative study of physical chemical properties of
aqueous solutions for the four candidate cleansing agents indicates that
Neutrogena alone of the four is subject to precipitation and gel formation
over the pH range of 2.5 to II.0 which might be encountered in a washwater
reclamation system. These results suggest that pH control might be import-
ant in a system used to reclaim washwater containing Neutrogena. They also
suggest that further effort in defining the physical chemical properties of
aqueous solutions of candidate cleansing agents should be performed in
order to identify more precisely the nature and severity of th'e potential
problems which could arise in washwater recovery.
4.0 CONCLUSIONS AND RECOMMENDATIONS
4.1 Conclusions
Analysis of the results obtained from the program have led to the
following conclusions:
(I)
(2)
(3)
(4)
(5)
The simulated Skylab personal hygiene regimen used in the
program, including the use of Neutrogena bar soap for
sponge bathing and hand washing and Miranol JEM for show-
ering, does not appear to cause any significant changes in
skin microflora.
None of the four cleansing agents tested (Neutrogena,
Miranol JEM, Olive Leaf, and Sodium dodecyl benzene
sulfonate), in the form of two per cent aqueous solutions,
were found to cause any adverse dermatological effects
after direct contact with the skin for up to two weeks.
Neutrogena and Miranol JEM were also found to have no
adverse dermatological effects on human subjects during
up to four weeks of use in the simulated Skylab personal
hygiene regimen (the other two cleansing agents were not
tested in this manner).
None of the four cleansing agents were found to serve as
general support media for microbiological growth. He_.Jever,
one specific type of a mold (presumably an Aspergillus) was
found to utilize a neutralized two per cent aqueous solu-
tion of Neutrogena.
None of the four cleansing agents tested were found to
exhibit definitive biocidal activity in concentrations
appropriate to washwater (0-2 per cent in water).
Except for Neutrogena, the cleansing agents tested e>'_ibited
stable aqueous solution properties over the pH range _]f 2.5
to II.0. The formation of stable gels and/or precipitates
in aqueous solutions of Neutrogena, near the extremes of
the pH range covered, suggest that potential system perform-
ance limitations could arise in the reclamation of wa_hwater
containing Neutrogena.
4.2 Recommendations
The following recommendations are submitted on the ba,,is of the
program results presented in this report:
(1)
(2)
(3)
(4)
Testing of Olive Leaf and sodium dodecyl benzene sulfonate
for possible adverse dermatological and other effects in a
use regimen should be performed in order to bring the state
of knowledge about these two cleansing agents to the same
level as for Neutrogena and Miranol JEM.
Other candidate cleansing agents for use on long-duration
space missions should also be tested similarly so that valid
comparison with those already tested can be made.
The physical chemical properties of candidate cleansir_g
agents in aqueous solution and in representative wash;-ater
solutions should be investigated in order to more clearly
define potential problem areas in washwater reclamation.
In the design of a reclamation system for washwater contain-
ing Neutrogena, care must be exercised to prevent gellation
or precipitate formation due to local or general pH excursions.
APPENDIX
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TABLE VIIA. SUBJECT A - MALE
Basel i ne
1 2 3
Shower
Reg,imen
4 5 6
BasEl
Site - Left Ear Canal
Cram (-) cocci 150 150
Gram (-) rods 150 150
Yeast/mol ds - -
Site - Right Arm Pit
Gram (-) cocci 73 20
Gram (-) rods 55 20
Yeast/tool ds - -
Site - Back of Left Hand
Gram (-) cocci - -
Gram (-) rods 27 -
Yeas t/mol ds - -
Site- Crotch Right Side
Gram (-) cocci 125 2
Gram (-) rods 4 -
Yeast/molds - -
Site - Rectum Left Side
Gram (-) cocci 15 9
Gram (-) rods 125 -
Yeast/molds - -
Site - Bottom Right Foot
Gram (-) cocci - -
Gram (-) rods - .9
Yeas t/mol ds - -
60
40
m
35
3
m
6
1 50 34 30
- 1 50 -
I0
4
125
35
20
2
I0
9
9OO
II
5
9OO
6
900
9
5
120
100
300
m
125
I00
140
9OO
120
120
25
900
150
1
1
900
15
900
÷
, G
s
T -
TABLE VIIB.
Baseline
SUBJECT B - MALE
Shower
Regimen Basel i n,,
l 2 3 4 5 6 8
Site - Left Ear Canal
Gram (-) cocci 1 90 90
Gram (-) rods - - 80
Yeast/molds - - -
Site - Right Arm Pit
Gram (-) cocci - - 12
Gram (-) rods 4 98 90
Yeast/molds - - -
Gram (+) cocci - - -
Site - Back of Left Hand
Gram (-) cocci - -
Gram (-) rods 1 -
Yeast/molds - -
Site - Crotch Right Side
Gram (-) cocci - -
Gram (-) rods - 20
Yeast/molds - -
Site - Rectum Left Side
2
m
B
16
3
Gram (-) cocci 2 90 5
Gram (-) rods - 90 90
Yeast/molds - - -
Site - Bottom Right Foot
Gram (-) cocci 120 125 23
Gram (-) rods - - -
Yeast/molds - -
5O
900
105
I0
II0
90 190
9O 20
90 75
900
5
1
18
18
II0
120
13
4
13
40
4O
5
9O
II0
2
34
165
m
1300
3
II0
TABLE VIIC.
Baseline
SUBJECT C - MALE
Shower
Regimen Baseline
3 9
Site - Left Ear Canal
Gram (-) cocci II0
Gram (-) rods 120
Yeast/mol ds
Site - Right Arm Pit
Gram (-) coccl
Gram (-) rods I15
Yeast/mol ds
Site - Back of Left Hand
Gram (-) coccl
Gram (-) rods
Yeast/mol ds
Site- Crotch Right Side
Gram (-) coccl II0
Gram (-) rods 950
Yeast/mol ds
Site - Rectum Left Side
Gram (-) coccl 900
Gram (-) rods 125
Yeas t/tool ds
Site - Bottom Right Foot
Gram (-) coccl 200
Gram (-) rods 120
Yeas t/tool ds
II0
D
m
1
8
N
p "
m
m
i
II0 120
m
3O
m
m
D
900 -
D
w m
15
n
1O0
TABLE VIID. SUBJECT D - MALE
Baseline
Shower
Regimen Basel i ne
1 2 3 4 5 6
Site - Left Ear Canal
Gram (-) cocci II0
Gram (-) rods
Yeast/molds
Site - Right Arm Pit
Gram C-) cocci
Gram (-) rods
Yeast/molds
Site - Back of Left Hand
Gram (-) coccl
Gram (-) rods 1
Yeast/molds
Site - Crotch Right Side
Gram (-) coccl 120
Gram (-) rods
Yeast/molds
Site - Rectum Left Side
Gram (-) cocci 70
Gram (-) rods 80
Yeast/tool ds
Site - Bottom Right Foot
Gram (-) coccl 43
Gram (-) rods
Yeas t/tool ds
II0 3 14 5 30
- 14 - - -
1O0
110
II0
5
II
14
35 -
B m
n
m
9O
1
92
1
16
92
25
m
n
m
2
2
B
B
25
1
25
5
15
i -
i 2
x
TABLE VIIE. SUBJECT E - MALE
Baseline
1 2 3
Shower
,Regimen
4 5 6
Baseline
Site - Left Ear Canal
Gram (-) coccl 38
Gram (-) rods
Yeast/molds
Site - Right Arm Pit
Gram (-) coccl
Gram (-) rods llO
Yeast/molds
Site - Back of Left Hand
Gram (-) coccl
Gram (-) rods
Yeas t/tool ds
Site- Crotch Right Side
Gram (-) cocci
Gram (-) rods
Yeas t/mol ds
Site - Rectum Left Side
Gram (-) coccl
Gram (-) rods
Yeast/tool ds
Site - Bottom Right Foot
Gram (-) coccl
Gram (-) rods
Yeast/mol ds
- 1
2
9
25 8O
25 16 92
- - l
l
4
45 900 1
- 900 -
12 I0 5
m
m
22
2
4
7
16
28
w
6
TABLE VIIF. SUBJECT F - FEMALE
Baseline
Shower
Regimen
1 2 3 4 5 6
Site - Left Ear Canal
Gram (-) cocci
Gram (-) rods
Yeas t/tool ds
Site - Right Arm Pit
Gram (-) cocci 45
Gram (-) rods
Yeas t/tool ds
Site - Back of Left Hand
Gram (-) coccl 15
Gram (-) rods
Yeast/molds
Site - Crotch Right Side
Gram (-) coccl
Gram (-) rods
Yeast/molds
Site - Rectum Left Side
Gram (-) coccl
Gram (-) Rods
Yeas t/tool ds
Site - Bottom Right Foot
Gram (-) coccl
Gram (-) rods
Yeast/molds
16
m
1
2
6
900
14 2
1
40 - -
- - 2
5 3 85
9O
1
m
N
n
m
m
N
1
900
3
85O
4
w
u
8
9
Basel i ne
8
II0
1
15
TABLE VIIG. SUBJECT G - MALE
Basel i ne
1 2 3
Shower
Regimen
4 5 6
Baseline
8
Site - Left Ear Canal
Gram (-) cocci -
Gram (-) rods
Yeast/mol ds
Site - Right Arm Pit
Gram (-) coccl -
Gram (-) rods 4
Yeast/mol ds
Site - Back of Left Hand
9O
m
Gram (-) cocci - -
Gram (-) rods - -
Yeast/molds - -
Site- Crotch Right Side
Gram (-) coccl -
Gram (-) rods 19
Yeast/tool ds
Site - Rectum Left Side
Gram (-) coccl - 95
Gram (-) rods - 875
Yeast/tool ds - -
Site - Bottom Right Foot
Gram (-) cocci
Gram (-) rods
Yeast/tool ds
255 125
250 -
b
950
m
4O
160
2
875
130
B
m
N
M
I m
3 -
m n
m
i D
90 -
30
12 -
130
B
m
w
m
80O
m
m
m
105
840
TABLE VIIH.
Baseline
SUBJECT H.- MALE
Shower
Regimen Baseline
1 2 3 4 5 6
Site - Left Ear Canal
Gram (-) cocci 6 - -
Gram (-) rods - - -
Yeas t/mol ds - - -
Site - Right Arm Pit
Gram (-) cocci - - -
Gram (-) rods 18 3 -
Yeast/molds - - -
Site - Back of Left Hand
Gram (-) cocci - 1 -
Gram (-) rods - - -
Yeast/molds - - -
Site- Crotch Right Side
Gram (-) cocci 30 50 -
Gram (-) rods 120 1 -
Yeast/tool ds - - -
Site - Rectum Left Side
Gram (-) cocci 125 120 -
Gram (-) rods 15 2 -
Yeast/molds - - -
Site - Bottom Right Foot
Gram (-) cocci 45 1 -
Gram (-) Rods 3 - -
Yeast/molds - - -
7 3
m
950 19
m
m
58
900
15
1
I0
900
n
950
890
900
m
m
m
m
m
m
125
H
9O0
4
850
900
9ZO
6
D
m
2
950
1
m
!
TABLE VII. I
Baseline
1 2
SUBJECT I - MALE
Shower Regimen
3 4 5 6
Baseline
8 9 1
Site - Left Ear Canal
Gram (-) cocci
Gram (-) rods
Yeas t/tool ds
Site - Ri9ht Am Pit
Gram (-) cocci
Gram (-) rods
Yeast/tool ds
Site - Back of Left Hand
Gram (-) cocci
Gram (-) rods
Yeas t/mol ds
Site - Crotch Right Side
Gram (-) coccl
Gram (-) rods
Yeast/mol ds
Site - Rectum Left Side
Gram (-) ceccl
Gram (-) rods
Yeast/tool ds
Site - Bottom Right Foot
Gram (-) cocci
Gram (-) rods
Yeast/tool ds
120 175 160 120 20 46
..... 34
25 125 8 135 25 26
..... 13
3
23
m
1 5O
m
15
21
18
165
27
135
m
m
n
5
15
120
D
130
45
120
115
128
m
1
250
125
130
145
3
6
2
210
8
41
125
120
120
950
1000
125
125
125
12
210 iI
150 -12
210
TABLE VII. J. SUBJECT J. - FEMALE
Baseline Shower Regimen
1 2 3 4 5 6 7
Basel i
8 9
Site - Left Ear Canal
Gram (-) cocci
Gram (-) rods
Yeast/molds
Site - Right Arm Pit
Gram (-) cocci
Gram (-) rods
Yeast/molds
Site - Back of Left Hand
Gram (-) cocci
Gram (-) rods
yeas t/tool ds
Site- Crotch Right Side
Gram (-) cocci
Gram (-) rods
Yeast/molds
Site Rectum Left Side
Gram (-) cocci
Gram (-) rods
Yeast/tool ds
Site - Bottom Right Foot
Gram (-) cocci
Gram (-) rods
Yeas t/mol ds
5 15 3 - 1 -
- - 3 - - -
15 2 5 -
- - 20 -
5 6
1 -
30 125 7 1
- 14
30 125 3 46 41 109
- - 20 - - 53
II 30 8 215
- 4 33 230
15 25
9 108
5
3
18
5
3
u
45
9
TABLE VIIK. SUBJECT K - FEMALE
Baseline
1 2
Shower Regimen
3 4 5 6
Baseline
7 8 9
Site - Left Ear Canal
Gram (-) cocci
Gram (-) rods
Yeast/mol ds
Site - Right Arm Pit
Gram (-) coccl
Gram (-) rods
Yeas t/tool ds
Site - Back of Left Hand
Gram (-) cocci
Gram (-) rods
Yeast/molds
Site- Crotch Right Side
Gram (-) cocci
Gram (-) rods
Yeast/molds
Site - Rectum Left Side
Gram (-) cocci
Gram (-) rods
Yeast/tool ds
Site - Bottom Right Foot
Gram (-) cocci
Gram (-) rods
Yeas t/tool ds
15
u
125
125
17
92 12 45 2 II 68 6
4 5 I0 12 4 - 5
6 23 2 125 16 130 1
3
m
15
125
160
n
m
m
125
120
m
8
109
1 20
230
115
35
m
78
215
195
54
4
110
III
115
m
m
9
88
215
108
190
230
125
5(
13<
TABLEVII.L
Baseline
SUBJECT L - FEMALE
Shower Regimen
3 4 5 6
Basel i ne
7 8 9
Site - Left Ear Canal
Gram (-) cocci 60
Gram (-) rods
Yeast/molds
Site - Right Arm Pit
Gram (-) coccl 8
Gram (-) rods
Yeast/molds
Site - Back of Left Hand
Gram (-) cocci 125
Gram (-) rods
Yeast/molds
Site- Crotch Right Side
Gram (-) coccl 130
Gram (-) rods
Yeast/tool ds
Site - Rectum Left Side
Gram (-) cocci 115
Gram (-) rods
Yeast/molds
Site - Bottom Riqht Foot
Gram (-) coccl
Gram (-) rods
Yeast/tool ds
II00
30 5 33 25 4 l 145 55
.......
m
4
1
2O
30
l
12
l
21
II00
i
l
l
112
m
l
4O
l
l
240
6O
5O
23
II0
21
l
24
l
15
I00
w
w
1
l
125
l
19 7 31 60
17 145 - -
4
7
12
130
l
55
l
130
l
l
l
l
250 3t
II0
TABLE VII.M.
Baseline
SUBJECT M - MALE
Shower Regimen Base
1 2 3 4 5 6 7 8
Site - Left Ear Canal
Gram (-) cocci
Gram (-) rods
Yeast/tool ds
Site - Right Arm Pit
Gram (-) coccl
Gram (-) rods
Yeast/tool ds
Site - Back of Left Hand
Gram (-) cocci
Gram (-) rods
Yeast/tool ds
Site- Crotch Right Side
Gram (-) cocci
Gram (-) rods
Yeas t/tool ds
Site - Rectum Left Side
Gram (-) cocci
Gram (-) rods
Yeast/molds
Site - Bottom Right Foot
Gram (-) cOCCl
Gram (-) rods
Yeas t/tool ds
2O
m
II0
u
135
D
125
II0
20 18 6
17
20
8
120
130
16
68
m
D
26
6
130
125
I00
42
45
15
2
135
2O
II0
120
125 130
36
1 _.5
m
m
6
m
135
125
16
1 20
ICO
1 ;0
1
i
II
9 ÷
r -
36
, -
- _
r
TABLE VII. O.
Baseline
SUBJECT O. - FEMALE
,,Shower Regimen
3 4 5 6 7
Basel I ] n
8 9
Site - Left Ear Canal
Gram (-) cocci 135
Gram (-) rods 9
Yeast/molds
Site - Right Arm Pit
Gram (-) coccl 7
Gram (-) rods 7
Yeast/molds l
Site - Back of Left Hand
Gram (-) cocci 4
Gram (-) rods
Yeas t/mol ds
Site- Crotch Right Side
Gram (-) cocci 114
Gram (-) rods 200
Yeast/tool ds
Site - Rectum Left Side
Gram (-) cocci II0
Gram (-) rods 20
Yeast/tool ds
Site - Bottom Right Foot
Gram (-) cocci 150
Gram (-) rods 30
Yeast/tool ds
140 135 70 40 23 22
- - 65 - - 125
9 4 - - - I0
- - 6 - - 1
5 II0 4 1 30 -
- - 3 1 - 3
60 130 II0 125 4 3
25 - 40 109 45 120
108 65 8 15 15 33
- - II - - 45
90 60 130 II0 120 25
60 210 55 108 250 130
1O0
30
125
5
5
16
19
I0
II0
21
250
125
125
8
II0
28
m
17
33
125
9O
240
230
L :
TABLE VII.P
Baseline
SUBJECT P - FEMALE
Shower Regimen
3 4 5 6
Baseli
7 8 9
Site - Left Ear Canal
Gram (-) coccl
Gram (-) rods
Yeas t/tool ds
Site - Right Arm Pit
Gram (-) cocci
Gram (-) rods
Yeast/mol ds
Site - Back of Left Hand
35
Gram (-) coccl
Gram (-) rods
Yeast/mol ds
Site- Crotch Right Side
Gram (-) coccl
Gram (-) rods
Yeas t/tool ds
Site - Rectum Left Side
125
II0
Gram (-) coccl 115
Gram (-) rods I00
Yeast/molds
Site - Bottom Right Foot
Gram (-) cocci
Gram (-) rods
Yeas t/tool ds
125
15
25
II0
135
35
21
115
120
u
125
45
I0
25
250
19
17
II
15
1
7
175
2
5O
3O
2
25O
115
T
T
=
TABLE Vll.O. SUBJECT Q - MALE
Baseline Shower Regimen Baseii
L ±
1 2 3 4 5 6 7 8
Site - Left Ear Canal
Gram (-) coccl
Gram (-) rods
Yeas t/mol ds
Site - Right Arm Pit
Gram (-) cocci
Gram (-) rods
Yeas t/mol ds
Site - Back of Left Hand
Gram (-) coccl
Gram (-) rods
Yeast/mol ds
Site- Crotch Right Side
15
120
45
120 - -
- 200 21 0
5O
25
II
60
20
40
15
7O 12
125
24
3O
170
125
150 iI
- _ -
=: _
2
I0 2,
| - -
5 _ -
- 1
-- T
r _
Gram (-) cocci
Gram (-) rods
Yeast/mol ds
125 60 150 150 - 2 5 15
.... 1 - 4 1
Site - Rectum Left Side
Gram (-) COCCl
Gram (-) rods
Yeast/mol ds
30
120
30
125
m
25
130 1 40
I0
2
7
27
125
21
4
13
Site - Bottom Right Foot
Gram (-) cocci 55
Gram (-) rods 30
Yeast/molds - =
62 60 8 18 40 16 76 12
35 45 I0 .... 13
TABLE VII.R. SUBJECT R. - MALE
Baseline Shower Regimen Baseli_:e
1 2 3 4 5 6 7 8 9
Site - Left Ear Canal
Gram (-) cocci
Gram (-) rods
Yeas t/mol ds
Site - Right Arm Pit
1 30
m
Gram (-) cocci
Gram (-) rods 125
Yeast/molds
Site - Back of Left Hand
Gram (-) cocci
Gram (-) rods
Yeast/mol ds
Site- Crotch Right Side
Gram (-) cocci
Gram (-) rods
Yeas t/mol ds
Site - Rectum Left Side
115
1 20
Gram (-) cocci I15
Gram (-) rods 8
Yeas t/tool ds
Site - Bottom Right Foot
Gram (-) cocci
Gram (-) rods
Yeast/tool ds
2
125
145 135 150 I00
- - - I0
130
25
m
125
95
6
85
4O
7.
II0
8
125
30
240
115
1 20
1 50
m
125
m
250
II0
I00
II0
135
2
25O
125
240
125
29
8
240
7
1
125
2
1 30
I19
10
110
125
125
18
120
II0
210
22
ISO
2O
ICO
120
2_0
_0
135
60
TABLE VII.S.
Baseline
SUBJECT S - MALE
Shower Reqimen Basel in
1 2 3 4 5 6 7 8
Site - Left Ear Canal
Gram (-) coccl
Gram (-) rods
Yeast/mol ds
Site - Right Arm Pit
15
25
65 18 15 -
- II0 106 3 m
4
115 I0;
Gram (-) coccl
Gram (-) rods 30
Yeast/tool ds
Site - Back of Left Hand
Gram (-) cocci
Gram (-) rods
Yeast/mol ds
8 15 3 - 34
11 - 2 - 50
21 5
I O8
15
1
Site - Crotch Right Side
Gram (-) cocci
Gram (-) rods
Yeast/tool ds
Site - Rectum Left Side
Gram (-) coccl II0
Gram (-) rods I00
Yeast/mol ds
Site - Bottom Right Foot
Gram (-) coccl 15
Gram (-) rods 125
Yeast/mol ds
15 125 130 130 240 210
6 5 - - 125 130
240
5
220
8
118
108
125
135
135
220
120
240
II0
230
1 08
230
1 28
115
108
225
1O0
225
II0
13i
TABLEVIII constitutes a reiteration of someof
the data recorded in Tables VII except that more detailed
information as to the specific organisms found is reported
for selected subjects and sites. The striking feature of
these data lies in the rather wide variations in numbers
of specific organisms found, coupled with the surpri_ingly
small variety of organisms found.
TABLE VIII
DETAILED DATA ANALYSIS OF SELECTED SUBJECTS
SUBJECT
SITE
A- Ear
A - Crotch
B - Rectum
D- Foot
E - Ear
H - Foot
G - Foot
ORGANISM
BASELINE REGIMEN
1 2 3 4 5 6
Staph (-) 150 150 60 150 34 30
Dipth (-) 150 150 40 - - -
E.Col i ......
Enterobacter .... 150 -
(-)
Staph (-) 25 2 35 125 5 -
Dipth (-) - - 3 - - 155
Bacillus (-) 4 .....
Proteus - - - 35 - 145
Strep (m) I00 .....
Enterobacter .... 900 -
(-)
Staph (-) 2 90 5 15 30 2
Strep (-) - - - 90 - -
Dipth (-) ......
Enterobacter - 90 ....
(-)
E. Coli - - 90 I0 - -
Bacillus .... 18 -
Yeast ..... . 5
Proteus ..... 40
Staph (-) 43 II0 14 92 92 1
Yeast ......
Staph (-) 38 9 - 25 16 92
Proteus ..... 1
Yeast - - 1 - - -
Staph (-) 45 1 - 5 890 -
Bacillus 3 - - - 900 -
Staph (-) 255 125
Neisseria 130 -
Enterobacter 120 -
(-)
130 130 -
BASELILE
7 8
125 150
I00 -
120 15
120 -
19 12
M
N
u N
m
- 5
- 15
22 16
920 950
- 1
N
m
L ±
2
TABLE VIII
DETAILED DATA AHALYSIS OF SELECTED SUBJECTS
SUBJECT BASE REGIMEN
SITE ORGANISM _ 2 3 4 5
I - Rectum Staph (-)
Strep (-)
E. Col i
Dipth (-)
Ci trobacter
J - Rectum Staph (-)
Dipth (-)
Ci trobacter
Enterococcus
K- Foot Staph (-)
Strep (-)
Oipth (-)
E.Col i
Klebsiella
M - Arm Staph (-)
Pit Dipth (-)
Proteus
0 - Crotch Staph (-)
Strep (-)
Dipth (-)
Enterobacter
E. Col i
II0
114
2O0
130
20
3O
125
17
17
2O
25
35
25
BASELI_
6 7 8
i¸ f
i
29 120 120 145 I00 120 : _ =-
136 - - 155 110 - _
- - 115 - - -
_ - - -I ?.5
1 25 3 46 41 109 1 5 _ i
- zu .... _
±
- 3 :
144 8 120 105 III 105
16 - II0 1!0 - II0 _i _ _=
_ - 115 17.0 - I08 i_ : __
- 109 - 75 115 - _
- - 9 1 6 6 :
26 45 3 ....
L g
130 II0 125 4 3 19 _.
_ -- ]
- - 109 45 120 I0
- 40 ...... _
z-
TABLE IX presents the numerical data which has
been summarized with plots of 1 + log N vs. time. From
these plots, which are typical of all the data, it is
clear that there is no significant variation in the
total microfloral populations introduced by the sim_-
lated Skylab personal regimen.
SUBJECT SITE
A Crotch
A Ear
B Rectum
TABLE IX
SKIN MICROORGANISM TOTALS - SELECTED DATA
TOTAL NO.ORGANISMS
SAMPLE N 1 + LOG N
Base 1 129 3.11
2 2 1.30
3 38 2.58
Reg. 4 160 3.20
5 905 3.96
6 300 3.48
Base 7 240 3.38
8 15 2.18
9 - 1.00
Base 1 300 3.48
2 300 3.48
3 I00 3.00
Reg. 4 150 3.18
5 184 3.26
6 30 2.48
Base 7 225 3.35
8 150 3.18
9 150 3.18
Base 1 2
2 180
3 95
Reg. 4 115
5 48
6 37
Base 7 _" 19
8 12
1.30
3.26
2.98
3,06
2.68
2.67
2.28
2.08
PLOT
Figure 1
Figure 1
Figure 2
SUBJECT SITE
D Foot
E Ear
H Foot
TABLE IX
SKIN MICROORGANISM TOTALS SELECTED DATA
TOTAL NO. ORGANISMS
SAMPLE N 1 + LOG N
Base 1 43 2.63
2 II0 3.04
3 14 2.15
Reg. 4 92 2.96
5 92 2.96
6 l 1. O0
Base 7 - l .00
8 20 2.30
9 l l .00
Base 1 38 2.58
2 9 1.95
3 - 1.00
Reg. 4 25 2.40
5 16 2.20
6 93 2.97
Base 7 22 2.34
8 16 2.20
9 6 1,78
Base 1 45
2 1
3
Reg. 4 5
5 1970
6
Base 7 920
8 951
-
9 940
2.65
1.00
1.70
4.25
3.96
3.98
3.97
PLO]
Figure 2
Figure 3
Figure 3
TABLE IX
SUBJECT
I
SKIN MICROORGANISM:TOTALS - SELECTED DATA
SITE
Rectum
Rectum
Foot
TOTAL NO.ORGANISMS
SAMPLE N l + LOG N
Reg. 2 36 2.56
3 162 3.21
4 130 3.11
5 128 3.10
6 175 3.24
7 49 2.69
Base 8 1950 4.29
9 360 3.56
I0 235 3.37
Base 1 30 2.48
Reg. 2 125 3.10
3 23 2.36
4 46 2.66
5 41 2.61
6 162 3.21
7 18 2.25
Base 8 45 2.65
9 235 3.37
Reg. 2 132 3.12
3 160 3.20
4 107 3.O3
5 345 3.54
6 410 3.61
7 225 3.35
Base 8 323 3.51
9 355 3.55
I0_ 180 3.26
PLOT
Figure 4
Figure _
Figure L
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